• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学腹膜癌症指数在恶性腹膜间皮瘤中的预后作用:全国队列研究。

Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.

机构信息

Department of Surgery, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Sci Rep. 2020 Aug 6;10(1):13257. doi: 10.1038/s41598-020-70044-8.

DOI:10.1038/s41598-020-70044-8
PMID:32764701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7411064/
Abstract

Malignant peritoneal mesothelioma (MPeM) is a rare cancer of the mesothelial cells of the peritoneum. Computed tomography (CT) is considered the standard for first-line imaging of MPeM, diagnosis and risk stratification remains challenging. Peritoneal cancer index (PCI), as assessed by CT, is utilized in the prognostic assessment of other malignant intra-abdominal conditions; however, there is limited data concerning the utility of PCI in the diagnosis and workup of MPeM. We studied a retrospective cohort of all patients diagnosed with MPeM from 2000 to 2012 in Finland. CT and magnetic resonance imaging (MRI) were reviewed and scored by an experienced and blinded, board-certified abdominal radiologist. Additional clinical data and outcomes were obtained from Finnish Cancer Registry (FCR), the Workers' Compensations Center (WCC), and Statistics Finland (SF). Abdominal CT or MRI was available for 53 of 90 patients. The median radiographic PCI was 25. PCI score was correlated with overall survival (p = 0.004, Exp(B) = 1.064, 95% CI 1.020-1.110). PCI score ≥ 30 was associated with worse survival (p = 0.002), while PCI ≤ 19 was associated with improved overall survival (p = 0.001). Our study indicates that radiological PCI is prognostic in MPeM and should be assessed during radiographic workup and integrated into clinical decision-making.

摘要

恶性腹膜间皮瘤(MPeM)是一种罕见的腹膜间皮细胞癌。计算机断层扫描(CT)被认为是 MPeM 一线成像的标准,但诊断和风险分层仍然具有挑战性。腹膜肿瘤指数(PCI),通过 CT 评估,用于其他恶性腹腔内疾病的预后评估;然而,关于 PCI 在 MPeM 的诊断和评估中的应用,数据有限。我们研究了芬兰 2000 年至 2012 年间所有诊断为 MPeM 的患者的回顾性队列。由一位经验丰富且盲法的、经过委员会认证的腹部放射科医生对 CT 和磁共振成像(MRI)进行了回顾和评分。额外的临床数据和结果来自芬兰癌症登记处(FCR)、工人赔偿中心(WCC)和芬兰统计局(SF)获得。53 名 90 名患者中有腹部 CT 或 MRI。中位数放射性 PCI 为 25。PCI 评分与总生存期相关(p = 0.004,Exp(B)= 1.064,95%CI 1.020-1.110)。PCI 评分≥30 与较差的生存相关(p = 0.002),而 PCI≤19 与总体生存率提高相关(p = 0.001)。我们的研究表明,放射性 PCI 在 MPeM 中具有预后意义,应在影像学检查中进行评估,并纳入临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/27de2b9a7866/41598_2020_70044_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/bac67082b488/41598_2020_70044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/f099622d5441/41598_2020_70044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/f7973e9bfd37/41598_2020_70044_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/27de2b9a7866/41598_2020_70044_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/bac67082b488/41598_2020_70044_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/f099622d5441/41598_2020_70044_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/f7973e9bfd37/41598_2020_70044_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/000e/7411064/27de2b9a7866/41598_2020_70044_Fig4_HTML.jpg

相似文献

1
Prognostic role of radiological peritoneal cancer index in malignant peritoneal mesothelioma: national cohort study.影像学腹膜癌症指数在恶性腹膜间皮瘤中的预后作用:全国队列研究。
Sci Rep. 2020 Aug 6;10(1):13257. doi: 10.1038/s41598-020-70044-8.
2
Epidemiology of malignant peritoneal mesothelioma: A population-based study.恶性腹膜间皮瘤的流行病学:一项基于人群的研究。
Cancer Epidemiol. 2017 Dec;51:81-86. doi: 10.1016/j.canep.2017.10.008. Epub 2017 Nov 5.
3
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.影像学在恶性腹膜间皮瘤诊断与管理中的作用:一项系统评价
Abdom Radiol (NY). 2022 May;47(5):1725-1740. doi: 10.1007/s00261-022-03464-x. Epub 2022 Mar 7.
4
[Prognostic value of new TNM staging and serum CA125 in malignant peritoneal mesothelioma].[新TNM分期及血清CA125在恶性腹膜间皮瘤中的预后价值]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 May 20;38(5):321-326. doi: 10.3760/cma.j.cn121094-20190821-00348.
5
Malignant Peritoneal Mesothelioma: Treatment Options and Survival.恶性腹膜间皮瘤:治疗选择与生存情况
Anticancer Res. 2019 Feb;39(2):839-845. doi: 10.21873/anticanres.13183.
6
Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.术前 CT 评估卵巢癌腹膜癌指数与手术结果和生存相关。
Radiol Med. 2020 Aug;125(8):770-776. doi: 10.1007/s11547-020-01170-6. Epub 2020 Apr 1.
7
What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative.评估腹膜癌指数的最佳术前成像方式是什么?来自美国腹腔热灌注化疗协作组的分析。
Clin Colorectal Cancer. 2020 Mar;19(1):e1-e7. doi: 10.1016/j.clcc.2019.12.002. Epub 2019 Dec 12.
8
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma.关于 CT 特征预测恶性腹膜间皮瘤患者治疗结局。
Eur J Surg Oncol. 2021 Sep;47(9):2212-2219. doi: 10.1016/j.ejso.2021.04.012. Epub 2021 Apr 14.
9
Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies.用于术前判定基于腹膜的恶性肿瘤可切除性的拟议放射学标准。
J Med Imaging Radiat Oncol. 2016 Jun;60(3):337-43. doi: 10.1111/1754-9485.12456. Epub 2016 Apr 21.
10
Nivolumab for malignant peritoneal mesothelioma.尼伏鲁单抗治疗恶性腹膜间皮瘤。
BMJ Case Rep. 2020 Nov 30;13(11):e237721. doi: 10.1136/bcr-2020-237721.

引用本文的文献

1
Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines.美国镭学会关于不同肿瘤起源的腹膜癌病管理的合理使用标准:系统评价与指南执行摘要
Cancer Med. 2025 Jul;14(14):e71043. doi: 10.1002/cam4.71043.
2
The rare occurrence of unifocal peritoneal mesothelioma: a case report, literature review, and future directions.单灶性腹膜间皮瘤的罕见病例:病例报告、文献综述及未来研究方向
J Gastrointest Oncol. 2024 Aug 31;15(4):1939-1947. doi: 10.21037/jgo-24-266. Epub 2024 Aug 20.
3
Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients.

本文引用的文献

1
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.细胞减灭术联合腹腔热灌注化疗治疗腹膜间皮瘤:患者选择及特殊考量
Cancer Manag Res. 2019 May 7;11:4231-4241. doi: 10.2147/CMAR.S170300. eCollection 2019.
2
Malignant Peritoneal Mesothelioma: Treatment Options and Survival.恶性腹膜间皮瘤:治疗选择与生存情况
Anticancer Res. 2019 Feb;39(2):839-845. doi: 10.21873/anticanres.13183.
3
Update on the management of malignant peritoneal mesothelioma.
在接受细胞减灭术治疗腹膜恶性肿瘤的患者中,剖腹手术时腹膜病变的形态表现与病理评估时疾病的相关性:PRECINCT 研究 I 期在 707 例患者中的结果。
Ann Surg Oncol. 2024 Dec;31(13):8560-8571. doi: 10.1245/s10434-024-16035-9. Epub 2024 Aug 26.
4
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma.国际肺癌研究协会间皮瘤分期项目:即将发布的第九版胸膜间皮瘤 TNM 分类中“T”描述符修订建议。
J Thorac Oncol. 2024 Sep;19(9):1310-1325. doi: 10.1016/j.jtho.2024.03.007. Epub 2024 Mar 21.
5
Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.甲硫腺苷磷酸化酶和乳腺癌 1 蛋白相关蛋白 1 作为腹膜间皮瘤的生物标志物。
Cancer Control. 2023 Jan-Dec;30:10732748231220805. doi: 10.1177/10732748231220805.
6
Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study.CD74、CD10 和 Ki-67 免疫组化表达在弥漫性恶性腹膜间皮瘤患者中的预后作用:一项回顾性研究。
BMC Cancer. 2023 May 5;23(1):406. doi: 10.1186/s12885-023-10871-w.
7
The role of imaging in diagnosis and management of malignant peritoneal mesothelioma: a systematic review.影像学在恶性腹膜间皮瘤诊断与管理中的作用:一项系统评价
Abdom Radiol (NY). 2022 May;47(5):1725-1740. doi: 10.1007/s00261-022-03464-x. Epub 2022 Mar 7.
8
Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database.原发性腹膜间皮瘤(PPM)的发病率、生存分析及未来展望:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Cancers (Basel). 2022 Feb 14;14(4):942. doi: 10.3390/cancers14040942.
9
Communicating imaging findings in peritoneal mesothelioma: the impact of 'PAUSE' on surgical decision-making.腹膜间皮瘤影像学检查结果的沟通:“PAUSE”对手术决策的影响
Insights Imaging. 2021 Nov 24;12(1):174. doi: 10.1186/s13244-021-01118-y.
恶性腹膜间皮瘤管理的最新进展
Transl Lung Cancer Res. 2018 Oct;7(5):599-608. doi: 10.21037/tlcr.2018.08.03.
4
Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review.腹膜间皮瘤的临床表现、诊断、分类及管理:综述
J Gastrointest Oncol. 2017 Oct;8(5):915-924. doi: 10.21037/jgo.2017.08.01.
5
Epidemiology of malignant peritoneal mesothelioma: A population-based study.恶性腹膜间皮瘤的流行病学:一项基于人群的研究。
Cancer Epidemiol. 2017 Dec;51:81-86. doi: 10.1016/j.canep.2017.10.008. Epub 2017 Nov 5.
6
Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.在英国一家转诊中心,对59例接受细胞减灭术和腹腔内热灌注化疗的腹膜间皮瘤患者进行完全细胞减灭的放射学预测因素。
Br J Radiol. 2017 Nov;90(1079):20170361. doi: 10.1259/bjr.20170361. Epub 2017 Aug 22.
7
Malignant peritoneal mesothelioma: a review.恶性腹膜间皮瘤:综述
Ann Transl Med. 2017 Jun;5(11):236. doi: 10.21037/atm.2017.03.96.
8
Predictive factors analysis for malignant peritoneal mesothelioma.恶性腹膜间皮瘤的预测因素分析
J Gastrointest Surg. 2015 Feb;19(2):319-26. doi: 10.1007/s11605-014-2664-4. Epub 2014 Oct 9.
9
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis.减瘤手术联合腹腔内热灌注化疗治疗恶性腹膜间皮瘤:一项系统评价和荟萃分析
Ann Surg Oncol. 2015 May;22(5):1686-93. doi: 10.1245/s10434-014-3978-x. Epub 2014 Aug 15.
10
Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma.影响 35 例恶性腹膜间皮瘤患者生存的预后因素。
Neoplasma. 2014;61(4):433-8. doi: 10.4149/neo_2014_053.